891 results on '"Hamelmann, Eckard"'
Search Results
2. Neue Leitlinie zur Allergen-Immuntherapie: Was ist für den Pneumologen wichtig
3. German Asthma Net – Was haben wir bisher gelernt?
4. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
5. Characterization of Austrian severe asthma patients
6. Characterization of Obesity in Severe Asthma in the German Asthma Net
7. 4/m mit chronischem Schnupfen und Husten: Vorbereitung auf die Facharztprüfung: Fall 97
8. Chronic stridor in a toddler after ingestion of a discharged button battery: a case report
9. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
10. German asthma net: Nasal polyposis in patients in the severe asthma registry
11. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
12. SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials
13. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
14. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
15. Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
16. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
17. White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics
18. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
19. An integrated molecular risk score early in life for subsequent childhood asthma risk.
20. Allergische Krankheiten
21. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children
22. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
23. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
24. Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy
25. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
26. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
27. Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis
28. Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort
29. DUPILUMAB REDUCES RESCUE SYSTEMIC CORTICOSTEROID USE IN CHILDREN WITH UNCONTROLLED MODERATE TO SEVERE ASTHMA REGARDLESS OF PRIOR EXACERBATION HISTORY
30. Initiation, response assessment and switch of antibody therapies in patients with severe asthma – a survey among German specialists
31. Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations
32. Dupilumab improves lung function responder rates in children with type 2 asthma in the VOYAGE study
33. Response to biologics and clinical remission in the adult GAN severe asthma cohort.
34. German Asthma Net: Nasal polyposis in patients with severe asthma
35. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry
36. Aktuelle Situation der allergologischen Versorgung an deutschen Kliniken
37. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach
38. Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype
39. Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
40. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
41. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
42. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy
43. Telemonitoring bei pädiatrischem Post-COVID-Syndrom
44. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
45. Current situation of allergological health care at German hospitals
46. Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study
47. Allergische Krankheiten
48. Allergische Krankheiten im Kindes- und Jugendalter
49. Stellenwert von Allergenexposition und allergenspezifischer Immuntherapie für die Prävention
50. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.